KPTI(Karyopharm Therapeutics Inc.) 的内部人交易:其他。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-16 | Abate Kristin | Chief Accounting Officer | 公开市场卖出 | 4,788 | $0.34 |
| 2026-10-01 | Abate Kristin | Chief Accounting Officer | 公开市场卖出 | 378 | $1.19 |
| 2026-09-01 | Abate Kristin | Chief Accounting Officer | 公开市场卖出 | 19 | $2.02 |
| 2026-07-28 | Poulton Stuart | EVP, Chief Development Officer | 公开市场卖出 | 189 | $7.10 |
| 2026-05-14 | Poulton Stuart | EVP, Chief Development Officer | 公开市场卖出 | 403 | $9.50 |
| 2026-05-14 | Rangwala Reshma | EVP & Chief Medical Officer | 公开市场卖出 | 408 | $9.50 |
| 2026-05-14 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | 公开市场卖出 | 324 | $9.50 |
| 2026-05-14 | Abate Kristin | Chief Accounting Officer | 公开市场卖出 | 53 | $9.50 |
| 2026-05-14 | Paulson Richard A. | President and CEO | 公开市场卖出 | 2,203 | $9.50 |
| 2026-05-14 | Mano Michael | EVP, CLO&Secretary | 公开市场卖出 | 266 | $9.50 |
| 2026-04-21 | Rangwala Reshma | EVP & Chief Medical Officer | 公开市场卖出 | 449 | $8.94 |
| 2026-03-02 | Abate Kristin | Chief Accounting Officer | 公开市场卖出 | 559 | $9.41 |
| 2026-03-02 | Poulton Stuart | EVP, Chief Development Officer | 公开市场卖出 | 5,101 | $9.41 |
| 2026-03-02 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | 公开市场卖出 | 4,604 | $9.41 |
| 2026-03-02 | Mano Michael | EVP, CLO&Secretary | 公开市场卖出 | 3,526 | $9.41 |
| 2026-03-02 | Rangwala Reshma | EVP & Chief Medical Officer | 公开市场卖出 | 5,066 | $9.41 |
| 2026-03-02 | Paulson Richard A. | President and CEO | 公开市场卖出 | 12,361 | $9.41 |
| 2026-02-17 | Poulton Stuart | EVP, Chief Development Officer | 公开市场卖出 | 378 | $8.63 |
| 2026-02-03 | Macomber Lori | EVP, CFO & Treasurer | 公开市场卖出 | 1,626 | $6.30 |
| 2026-01-28 | Abate Kristin | Chief Accounting Officer | 公开市场卖出 | 50 | $7.03 |